Emerging Market and Trends in Global Autoimmune Monoclonal Antibodies April.2017 | Page 3
Global Autoimmune Monoclonal Antibodies Market
Research Institute
Diagnostic Laboratories
4. On the basis of Geography
North America
Europe
Asia-Pacific
Latin America
Middle-East & Africa
The key players in global Autoimmune Monoclonal Antibodies market include, GlaxoSmithKline plc
(U.K.), AstraZeneca plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.),
Johnson & Johnson (U.S.), Innovent Biologics, Inc. (China), Takeda Pharmaceutical Company Ltd.
(Japan), Amgen Inc. (U.S.), Biogen Inc.(U.S.), and UCB Company (Belgium).
TABLE OF CONTENTS
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
+1 888-702-9626 | www.marketdataforecast.com | [email protected]